Scoliosis Treatment Market Research Report - Forecast till 2027

Scoliosis Treatment Market Research Report: Information by Disease (Infantile Idiopathic Scoliosis and Adolescent Idiopathic Scoliosis), Product (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Thoracolumbosacral Orthosis (TLSO) and Lumbosacral Orthosis (LSO)), Distribution Channel (Hospitals & Clinics, Retail Pharmacies and Online Pharmacies) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6758-HCR | February 2021 | Region: Global | 95 pages

Scoliosis Treatment Market Overview


The Scoliosis Treatment Market will grow at a rate of 3.9 percent during Forecast period till 2025. The Scoliosis Treatment Market was valued at USD 2,580.2 million in 2018. The market is a growing one and will not stagnate over the forecast period. The Scoliosis Treatment Market is a major healthcare segment for the global healthcare market. As global healthcare gains in importance, Market will also see growth and progress over many aspects. The Market will continue to grow even till 2028 despite the different challenges it operates under.


In this Scoliosis Treatment Market Report, we will discuss the key drivers of the market, the trends and regional segmentation of the market, and the overall potential of the Market in the future.  Scoliosis is a disease that leads to spinal deformity and neural problems. Scoliosis is very common in children. Scoliosis is a health condition that leads to an abnormal curvature of the spine that alters the alignment of the vertebrae. Scoliosis has a huge impact on a person’s posture and balance because of the curving of the spinal axis. Scoliosis is less prevalent in adults. More teens suffer from the disease.


Scoliosis can arise from a birth defect, being congenital in nature. The disease can also be idiopathic. There are many causes of Scoliosis. These causes are weak ligaments, spondylolysis, bad posture, etc. When the patient suffers from Scoliosis, the person needs to undergo treatment. The treatment usually includes the use of braces. Braces keep the spine in its place and fix the body alignment. The braces have to be worn all the time. In severe cases, the Scoliosis management technique changes a lot. The patient with a severe case of Scoliosis needs to go through surgery. The doctor puts in implants to support the spine.


COVID 19 impact


The COVID 19 pandemic has impacted every other market in the world. The Market is no stranger to the impact of the COVID 19 pandemic. The Scoliosis Treatment Market saw an initial dip due to the impact of the pandemic. This was because most of the healthcare resources were channeled into COVID 19 treatment. This put other healthcare markets at a growth disadvantage. The immediate impact of the pandemic has been bad for the Market.


However, the long-term impact of the COVID 19 impact is increased attention to healthcare. There is a focus on complete wellbeing that was not present before. People are more aware of their healthcare needs and take multiple approaches to cure a disease. While the COVID 19 virus remains a primary concern, people’s attention towards overall wellbeing means that the Scoliosis Treatment Market has the advantage to work with. Due to the research and development of alternative approaches to Scoliosis disease management, the Market will grow.


Market Dynamics


Key Drivers


There are certain drivers of the Scoliosis Treatment Market that influence the market in a major way. Advancement in general in the Scoliosis Treatment Market applications and the increased incidence of Scoliosis in children and adults drive the growth of the market. The Market Growth will be supported by the advancement of new approaches to Scoliosis Treatment. The incidence of Scoliosis disease in the global population is also a key driver for the Market Size. According to the Clear Scoliosis Institute, Scoliosis is the most common type of spinal deformity among school children. In fact, every year nearly 17, 500 emergency visits happen from Scoliosis in children. With such prevalence of Scoliosis in small children, the Market grows through the forecast period.


Opportunities


The increased incidence of adult scoliosis due to lifestyle issues is also an opportunity for Scoliosis Treatment Market growth. Adults suffer from Scoliosis due to different reasons such as bad posture, lifestyle changes, and way too much stress to the spine. Adult scoliosis patients need long-term care. This means that an average adult scoliosis patient will require prolonged treatment and medical attention. Therefore, the Scoliosis Treatment Industry will benefit from a single Scoliosis patient for a long time.


Restraints


There are some restraints in the Scoliosis Treatment Market that hamper the growth of the market. The presence of rashes and skin irritation due to Scoliosis Treatment approaches like braces are one market restraint. The braces are long-term care options that will cause skin rash and irritation in many people. Therefore, the braces are not comfortable to wear. This creates a hindrance for the adoption of Scoliosis Treatment approaches by patients. This leads to a decrease in a brace and other implant sales. An inherent fear of spinal surgery among people, especially parents of young children, is also a market restraint for the Scoliosis Treatment Industry.


Challenges in the market


The challenges in the Scoliosis Treatment Market that need to be addressed are lack of awareness and lack of options.  A larger section of the patient population is not aware of the treatment options they have to treat Scoliosis. This leads to the disease becoming chronic for people. On the other hand, this means that they do not really seek treatment for the disease. This takes away the opportunity of expansion for the Scoliosis Treatment Industry Size. Another challenge is the limited options of Scoliosis Treatment. There is a lack of options which has led to the high cost of treatments in the sector. If there is ample research and development, the Scoliosis Treatment Industry will see more accessibility and Scoliosis Treatment Industry Growth. This will happen as an increased number of people goes for Scoliosis Treatment approaches.


Cumulative Growth Analysis


The Scoliosis Treatment Market has great growth prospects in the future, provided the market challenges are resolved. The market will see an organic growth spurt because of increased awareness of health conditions and treatments on a global scale. On the other hand, according to Scoliosis Treatment Market Analysis, the growth trends will not be uniform. 


Segment Overview


The Scoliosis Treatment Market divides into different segments based on different categories. The major categories of the Scoliosis Treatment Market Analysis by segment are disease, product, and distribution channels.


By disease- By disease, the Market divides into infantile idiopathic Scoliosis and adult idiopathic Scoliosis.


By Product- The Market divides into cervical, thoracic, CTLSO, TLSO, and LSO approaches.


By distribution channel- By distribution channels, the major channels for Scoliosis Treatment approaches are hospitals, clinics, and pharmacies.


The regional analysis of the Market is stated below.


Regional overview


The Scoliosis Treatment Market disperses over different regions of the world. The classification of the Scoliosis Treatment Industry according to regions includes North America, Europe, Asia Pacific, Middle East, and African region. The North American region will have the highest Scoliosis Treatment Industry share due to many reasons. The European market also shows promising signs of growth in the Scoliosis Treatment Industry Forecast period. The Asia Pacific region also has moderate growth projections in the future. However, the African region will have the lowest growth rate in the Scoliosis Treatment Industry share.


Competitive landscape 


There are many key players in the Market that dominate the competitive landscape for the market. 


The key players of the Scoliosis Treatment Market segment are as follows:



  • Boston Orthotics & Prosthetics

  • Chaneco

  • Charleston Bending Brace

  • Orthotech

  • Trulife

  • Össur

  • DJO


Recent Developments


The key players of the Scoliosis Treatment Industry are taking up further research and development to support the sector. The competitors are getting into collaborations and acquisitions. There are some who are merging too. For example, in 2020, Convexity Scientific acquired Wellinks Inc. In March 2019, another company Green Sun Medical conducted a pilot study into Dynamic Scoliosis Braces to introduce this new tech into the market.


Report Overview 


The Scoliosis Treatment Market Outlook or overview is as follows 



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Segment Overview

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This report focuses on the Scoliosis Treatment Market trends and their growth projections. It highlights the key drivers, significant opportunities for growth, and presents market challenges of the Scoliosis Treatment Industry. Thirdly, it discusses the segmentation of the Scoliosis Treatment Industry over various benchmarks and segments. Additionally, the Scoliosis Treatment Industry Outlook sheds more light on the competitive landscape and recent developments of the market. It creates an overall reading of the Scoliosis Treatment Industry trends and future possibilities for the readers. 



Frequently Asked Questions (FAQ) :


The scoliosis treatment market is projected to grow at a 3.9% CAGR between 2019-2025.

The Americas are predicted to have the largest share in the scoliosis treatment market.

Rising prevalence of scoliosis & musculoskeletal disorders and growing demand for spine injuries are boosting market growth.

Lack of awareness and high cost may restrict market growth.

Hospitals and clinics will dominate the scoliosis treatment market?

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Product Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Scoliosis Treatment Market, by Disease

6.1 Introduction

6.2 Infantile Idiopathic Scoliosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Adolescent Idiopathic Scoliosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Scoliosis Treatment Market, by Product

8.1 Introduction

8.2 Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Thoracolumbosacral Orthosis (TLSO)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Lumbosacral Orthosis (LSO)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Scoliosis Treatment Market, by Distribution channel

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Retail Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Online Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Market Estimates & Forecast, by Country, 2020-2027

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Boston Orthotics & Prosthetics

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Chaneco

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Charleston Bending Brace

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Orthotech

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Trulife

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Össur

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 DJO

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 SPINEFORM LLC

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Wilmington Orthotics & Prosthetics, Inc.

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Lawall Prosthetics and Orthotics

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Horton's Orthotics & Prosthetics

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Aspen Medical Products

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 UNYQ

12.13.1 Overview

12.13.2 Product Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 C H Martin Company

12.14.1 Overview

12.14.2 Product Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Optec USA, Inc.

12.15.1 Overview

12.15.2 Product Overview

12.15.3 Financials

12.15.4 Key Developments

12.15.5 SWOT Analysis

12.16 Spinal Technology, Inc.

12.16.1 Overview

12.16.2 Product Overview

12.16.3 Financials

12.16.4 Key Developments

12.16.5 SWOT Analysis

12.17 Zimmer Biomet Holdings Inc.

12.17.1 Overview

12.17.2 Product Overview

12.17.3 Financials

12.17.4 Key Developments

12.17.5 SWOT Analysis

12.18 NuVasive

12.18.1 Overview

12.18.2 Product Overview

12.18.3 Financials

12.18.4 Key Developments

12.18.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Cell Surface Markers Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Scoliosis Treatment Market Synopsis, 2020-2027

Table 2 Global Scoliosis Treatment Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Scoliosis Treatment Market, by Region, 2020-2027 (USD Million)

Table 4 Global Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 5 Global Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 6 Global Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 7 North America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 8 North America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 9 North America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 10 Latin America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 11 Latin America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 12 Latin America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 13 Europe: Scoliosis Treatment Market, by Disease tye, 2020-2027 (USD Million)

Table 14 Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 15 Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 16 Western Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 17 Western Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 18 Western Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 19 Eastern Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 20 Eastern Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 21 Eastern Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 22 Asia-Pacific: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 23 Asia-Pacific: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 24 Asia-Pacific: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 25 Middle East & Africa: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 26 Middle East & Africa: Scoliosis Treatment Market, by Product, 2020-2027

(USD Million)

Table 27 Middle East & Africa: Scoliosis Treatment Market, by Distribution channel, 2020-2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Scoliosis Treatment Market

Figure 3 Market Dynamics for Global Scoliosis Treatment Market

Figure 4 Global Scoliosis Treatment, by Disease, 2020

Figure 5 Global Scoliosis Treatment Market Share, by Product, 2020

Figure 6 Global Scoliosis Treatment Market Share, by Distribution channel, 2020

Figure 7 Global Scoliosis Treatment Market Share, by Region, 2020

Figure 8 North America: Scoliosis Treatment Market Share, by Country, 2020

Figure 9 Europe: Scoliosis Treatment Market Share, by Country, 2020

Figure 10 Asia-Pacific: Scoliosis Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa: Scoliosis Treatment Market Share, by Country, 2020

Figure 12 Global Scoliosis Treatment Market: Company Share Analysis, 2020 (%)

Figure 13 Boston Orthotics & Prosthetics, Inc.: Key Financials

Figure 14 Boston Orthotics & Prosthetics, Inc.: Segmental Revenue

Figure 15 Boston Orthotics & Prosthetics, Inc.: Geographical Revenue

Figure 16 Chaneco Medical Solutions: Key Financials

Figure 17 Chaneco Medical Solutions: Segmental Revenue

Figure 18 Chaneco Medical Solutions: Geographical Revenue

Figure 19 Charleston Bending Brace: Key Financials

Figure 20 Charleston Bending Brace: Segmental Revenue

Figure 21 Charleston Bending Brace: Geographical Revenue

Figure 22 Orthotech: Key Financials

Figure 23 Orthotech: Segmental Revenue

Figure 24 Orthotech: Geographical Revenue

Figure 25 Trulife: Key Financials

Figure 26 Trulife: Segmental Revenue

Figure 27 Trulife: Geographical Revenue

Figure 28 Össur: Key Financials

Figure 29 Össur: Segmental Revenue

Figure 30 Össur: Geographical Revenue

Figure 31 DJO: Key Financials

Figure 32 DJO: Segmental Revenue

Figure 33 DJO: Geographical Revenue

Figure 34 SPINEFORM LLC: Financials

Figure 35 SPINEFORM LLC: Segmental Revenue

Figure 36 SPINEFORM LLC: Geographical Revenue

Figure 37 Wilmington Orthotics & Prosthetics, Inc.: Key Financials

Figure 38 Wilmington Orthotics & Prosthetics, Inc.: Segmental Revenue

Figure 39 Wilmington Orthotics & Prosthetics, Inc.: Geographical Revenue

Figure 40 Lawall Prosthetics and Orthotics: Key Financials

Figure 41 Lawall Prosthetics and Orthotics: Segmental Revenue

Figure 42 Lawall Prosthetics and Orthotics: Geographical Revenue

Figure 43 Horton's Orthotics & Prosthetics: Key Financials

Figure 44 Horton's Orthotics & Prosthetics: Segmental Revenue

Figure 45 Horton's Orthotics & Prosthetics: Geographical Revenue

Figure 46 Aspen Medical Products: Key Financials

Figure 47 Aspen Medical Products: Segmental Revenue

Figure 48 Aspen Medical Products: Geographical Revenue

Figure 49 UNYQ: Key Financials

Figure 50 UNYQ: Segmental Revenue

Figure 51 UNYQ: Geographical Revenue

Figure 52 C H Martin Company: Key Financials

Figure 53 C H Martin Company: Segmental Revenue

Figure 54 C H Martin Company: Geographical Revenue

Figure 55 Optec USA, Inc.: Key Financials

Figure 56 Optec USA, Inc.: Segmental Revenue

Figure 57 Optec USA, Inc.: Geographical Revenue

Figure 58 Spinal Technology, Inc.: Key Financials

Figure 59 Spinal Technology, Inc.: Segmental Revenue

Figure 60 Spinal Technology, Inc.: Geographical Revenue

Figure 61 Zimmer Biomet Holdings Inc.: Key Financials

Figure 62 Zimmer Biomet Holdings Inc.: Segmental Revenue

Figure 63 Zimmer Biomet Holdings Inc.: Geographical Revenue

Figure 64 NuVasive: Key Financials

Figure 65 NuVasive: Segmental Revenue

Figure 66 NuVasive: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.